We serve Chemical Name:[2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol CAS:658076-79-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:[2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol
CAS.NO:658076-79-0
Synonyms:[2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol
Molecular Formula:C10H10N2OS
Molecular Weight:206.26400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:87.38000
Exact Mass:206.05100
LogP:2.46580
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like [2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol Use and application,[2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol technical grade,usp/ep/jp grade.
Related News: He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. [2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol manufacturer Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. [2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. [2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol vendor The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy. [2-(2-aminophenyl)-1,3-thiazol-4-yl]methanol factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.